Skip to content
PPepIndex

Evidence digest

What the research on BPC-157 actually shows

The published BPC-157 literature is preclinical. It consists of rodent injury models and cell-culture work; there are no controlled human trials in the indexed literature. That is the single most important thing to know about this compound, because vendor copy routinely describes rodent findings in language that implies a human effect. Animal results are a reason to run a human trial, not a substitute for one.

Updated 22 Jul 2026 · 3 studies indexed · no human evidence · compound record

Studies indexed
3
Human evidence
0
Preclinical only
3

What is and is not established

What the literature supports

  • A body of rodent work exists across tendon, muscle and gastrointestinal injury models, reporting outcomes measured in those animals.
  • In vitro work reports effects on cultured fibroblast migration and proliferation.
  • The peptide is a synthetic 15-amino-acid sequence derived from a sequence identified in gastric juice.
  • It is widely listed by vendors in this index, and certificate records exist for several of them.

What is NOT established

  • No controlled human trial appears in the indexed literature. Nothing here establishes an effect in people.
  • No safety profile in humans has been characterised — not dose-limiting toxicity, not long-term exposure, not interactions.
  • No regulator has approved it for any indication in any jurisdiction.
  • Rodent injury-model results do not establish that the same outcome occurs in human tissue, and this literature does not claim otherwise.
  • No pharmacokinetic profile in humans is established, including whether the compound survives oral administration.

Studies indexed

2 animal · 1 in vitro
Each row links to that study's permalink, where every digest citing it is listed. Findings are reported as the paper reported them — an animal result is not restated as a human one.
StudyEvidence typeModelnWhat it reportedSource
Preclinical rodent work on BPC-157 and tendon healingPubMed listingAnimalRat, transected Achilles tendon model—Placeholder seed record. The listed literature reports outcomes in rodent tendon-injury models. Endpoints are histological and biomechanical measurements in animals; no human endpoint is reported in this body of work.Listing
Preclinical rodent work on BPC-157 in gastrointestinal injury modelsPubMed listingAnimalRat, induced gastric lesion model—Placeholder seed record. The listed literature reports mucosal outcomes in induced gastrointestinal lesion models in rodents. The originating sequence was identified in gastric juice; the material sold under this name is synthetic.Listing
In vitro work on BPC-157 and fibroblast activityPubMed listingIn vitroCultured fibroblasts—Placeholder seed record. Cell-culture work examining fibroblast migration and proliferation. In vitro results describe cell behaviour in a dish and do not establish an effect in a living organism of any species.Listing

Regulatory status

Full feed →
FDACompounding list

FDA bulk drug substances nominated for compounding — 503A and 503B lists

Placeholder seed entry recording the source, not an event. The FDA maintains categorised lists of bulk drug substances nominated for use in compounding, including substances it has evaluated and placed in the category that may not be compounded. Several peptides tracked in this index have appeared in these evaluations. PepIndex records movements between categories here as they are observed; the linked page is the authoritative listing.

SemaglutideBPC-157IpamorelinCJC-1295

Vendors listing BPC-157

Ranked view →

The evidence above describes the published literature. What any individual vial contains is a separate question, answered by that vendor’s certificate records rather than by any study on this page.

VendorScore · CoverageCertificates
Curo93.877%1profile →
Polaris Peptides93.877%3profile →
Next Gen Peptides93.897%3profile →
Amino Club90.495%1profile →
PeptidePlugs89.790%5profile →
Hydro Research Peptides88.289%2profile →
Protide Health83.994%1profile →
American Peptides83.6100%1profile →
Origin Labs81.885%0profile →
Northline Labs79.493%3profile →
NeuroLabs Research79.386%2profile →
Koi Peptides79.394%0profile →
ZC Labs79.384%2profile →
Good Science Bio79.275%0profile →
Ascension Peptides78.186%3profile →
Licensed Peptides7789%1profile →
Peptime75.359%1profile →
Paramount Peptides74.256%0profile →
Modern Aminos74100%2profile →
Simple Peptide7489%1profile →
True Research Labs71.971%0profile →
GenX Peptides70.868%0profile →
Vertex Labs70.170%0profile →
Improved Peptides7089%1profile →
Disguised Alpha69.150%0profile →
Eternal Peptides68.265%0profile →
Biotech Peptides6863%0profile →
BioLongevity Labs67.274%0profile →
Evolve Peptides65.567%0profile →
Mile High Compounds65.494%0profile →
Extreme Peptides64.282%0profile →
Sports Technology Labs56.174%0profile →

How to read this page

This digest describes what published research exists and what it does not establish. It is not a recommendation, contains no dosing information or protocols, and makes no claim that any compound is safe or effective for any purpose. Material listed by indexed vendors is labeled for laboratory research use only.